Anti-Obesity Medications as Medicare Part D Drugs - Legal and Health Policy Rationales

Manatt, Phelps & Phillips, LLP

Obesity is a complex, multifactorial disease that has serious health consequences, affects millions of Americans and drives hundreds of billions of dollars in annual health care spending. Scientific understanding of the nature of obesity has evolved over the course of the past several decades. It is now clinically recognized that obesity is a disease, not simply a cosmetic concern or issue of personal behavior. We now have a much greater understanding of obesity’s various metabolic implications and direct links to cardiovascular disease, type 2 diabetes, liver disease and certain types of cancer, among other diseases. Multiple prescription medications have been developed, approved and recognized as safe and effective for long-term use in treating obesity

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Manatt, Phelps & Phillips, LLP | Attorney Advertising

Written by:

Manatt, Phelps & Phillips, LLP

Manatt, Phelps & Phillips, LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide